These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 4546419)
21. [Vaccine allergy--does it exist? Type 1-reaction after vaccination of children is uncommon]. Rietz H; Lilja G; Hedlin G Lakartidningen; 1994 Aug; 91(35):3044-6. PubMed ID: 7983937 [No Abstract] [Full Text] [Related]
23. The present situation of prophylactic vaccination in Japan for travel abroad. Nakano T Travel Med Infect Dis; 2008 Nov; 6(6):342-8. PubMed ID: 18984478 [TBL] [Abstract][Full Text] [Related]
24. Prospects for development of vaccines against fungal diseases. Dan JM; Levitz SM Drug Resist Updat; 2006 Jun; 9(3):105-10. PubMed ID: 16820318 [TBL] [Abstract][Full Text] [Related]
25. Prophylaxis of hepatitis type B: immunoglobulins and vaccines. Zuckerman AJ Clin Gastroenterol; 1980 Jan; 9(1):65-83. PubMed ID: 6994953 [No Abstract] [Full Text] [Related]
26. [Unsolved problems of vaccination according to epidemiological indications]. Sergiev VP Pediatriia; 1980 Dec; (12):52-3. PubMed ID: 7220180 [No Abstract] [Full Text] [Related]
27. Passive and active immunoprophylaxis of hepatitis B. Seeff LB; Koff RS Gastroenterology; 1984 May; 86(5 Pt 1):958-81. PubMed ID: 6231210 [No Abstract] [Full Text] [Related]
31. Vaccinations against Pseudomonas aeruginosa: active and passive alternatives. Bellanti JA; Zeligs BJ; Kulczycki LL Pediatr Pulmonol Suppl; 1997; 16():269-70. PubMed ID: 9443307 [No Abstract] [Full Text] [Related]
32. [Active and passive immunoprevention of hepatitis B in newborn infants with HBsAg-positive mothers]. Vierucci A; Resti M; Appendino C; Rossi ME; De Martino M; Ulivelli A Pediatr Med Chir; 1984; 6(1):35-44. PubMed ID: 6335750 [TBL] [Abstract][Full Text] [Related]
33. Vaccinations in the presence of skin diseases. Weber G; Falk U Int J Dermatol; 1975 Mar; 14(2):136-40. PubMed ID: 1123260 [TBL] [Abstract][Full Text] [Related]
34. Immunisation in the current management of cystic fibrosis patients. Malfroot A; Adam G; Ciofu O; Döring G; Knoop C; Lang AB; Van Damme P; Dab I; Bush A; J Cyst Fibros; 2005 May; 4(2):77-87. PubMed ID: 15978534 [TBL] [Abstract][Full Text] [Related]
35. Index to immunization. Bingham B Va Med; 1982 Jun; 109(6):373-9. PubMed ID: 7113401 [No Abstract] [Full Text] [Related]
37. [Current status of immunization in the Armed Forces: need of continuous adaptation of vaccinations against cerebrospinal meningitis, typhoid and hepatitis A]. Meyran M; Buisson Y; Desfontaine M Ann Gastroenterol Hepatol (Paris); 1994 Oct; 30(5):227-31. PubMed ID: 7802441 [TBL] [Abstract][Full Text] [Related]
38. [Passive and active immunoprophylaxis of hepatitis A. New vaccines]. Grzeszczuk A Przegl Epidemiol; 1997; 51(4):417-24. PubMed ID: 9562789 [TBL] [Abstract][Full Text] [Related]
39. [Safety of vaccination in connective tissue diseases]. Sikora A Pol Arch Med Wewn; 2004 Aug; 112(2):1003-8. PubMed ID: 15675278 [No Abstract] [Full Text] [Related]
40. [Associated live vaccine against influenza, adenovirus type 4 and Mycoplasma pneumoniae]. Smorodintsev AA; Kolesnikov LV Tr Inst Im Pastera; 1982; 58():3-13. PubMed ID: 6821264 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]